Related Experiment Video
Updated: Aug 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Abrogation of transforming growth factor-beta signaling in pancreatic cancer
1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Room 131D, Houston, Texas 77030, USA. xialin@bcm.tmc.edu
Abstract:
Transforming growth factor-beta (TGFbeta) functions as a growth inhibitor for many cell types by inhibiting cell cycle progression. Loss of TGFbeta responsiveness can lead to deregulated cell proliferation and ultimately tumor progression. For example, the TGFbeta signaling pathway is a frequent target for inactivation in pancreatic cancer. Functional connection between the potent growth inhibitory activity of TGFbeta and the tumor suppressor activity of Smads has been well documented. Smads directly modulate transcription of the genes involved in cell cycle progression in response to TGFbeta, and that abrogation of this regulation leads to tumor progression. In this review, we summarize recent research progress on TGFbeta signaling and pancreatic cancer.
Insights
Transforming growth factor-beta (TGFbeta) inhibits cell growth. Loss of TGFbeta signaling contributes to pancreatic cancer progression by enabling uncontrolled cell proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Transforming growth factor-beta (TGFbeta) is a key regulator of cell growth, acting as a potent inhibitor for many cell types by arresting cell cycle progression.
- Loss of responsiveness to TGFbeta signaling is a critical event in tumorigenesis, promoting uncontrolled cell proliferation and tumor progression.
- The TGFbeta signaling pathway is frequently inactivated in pancreatic cancer, highlighting its role in this disease.
Purpose of the Study:
- To review recent research on the role of TGFbeta signaling in pancreatic cancer.
- To elucidate the functional connection between TGFbeta's growth inhibitory activity and Smad-mediated tumor suppression.
- To summarize how Smad proteins regulate gene transcription in response to TGFbeta and how disruptions lead to cancer.
Main Methods:
- Literature review of recent research findings.
- Analysis of molecular mechanisms underlying TGFbeta signaling.
- Examination of the role of Smad proteins in cell cycle regulation and tumor suppression.
Main Results:
- TGFbeta signaling loss is implicated in the progression of pancreatic cancer.
- Smad proteins are crucial mediators of TGFbeta's tumor suppressor activity by modulating cell cycle gene transcription.
- Disruption of TGFbeta-Smad pathway regulation contributes to deregulated proliferation and tumor development.
Conclusions:
- TGFbeta signaling is a critical tumor suppressor pathway frequently dysregulated in pancreatic cancer.
- Understanding TGFbeta-Smad interactions is vital for developing targeted therapies for pancreatic cancer.
- Restoring TGFbeta responsiveness or Smad function may offer therapeutic strategies against pancreatic cancer.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

